Edition:
United Kingdom

Tecogen Inc (TGEN.OQ)

TGEN.OQ on NASDAQ Stock Exchange Capital Market

2.31USD
23 Feb 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.31
Open
$2.30
Day's High
$2.34
Day's Low
$2.30
Volume
5,019
Avg. Vol
4,890
52-wk High
$4.17
52-wk Low
$2.09

Chart for

About

Tecogen Inc. designs, manufactures, sells and maintains cogeneration products, including combined heat and power (CHP), air conditioning systems and water heaters for residential, commercial, recreational and industrial use. The Company is engaged in the business of manufacturing and supporting CHP products based on engines... (more)

Overall

Beta: 1.08
Market Cap(Mil.): $80.32
Shares Outstanding(Mil.): 24.71
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 14.62 16.60
EPS (TTM): -- -- --
ROI: -- 17.26 10.66
ROE: -- 22.04 14.30

BRIEF-Tecogen sells Two Inverde E+ Cogeneration Units

* TECOGEN INC - ANNOUNCES SALE OF TWO INVERDE E+ COGENERATION UNITS TO A LIGHT MANUFACTURING COMPANY IN BROOKLYN, NY Source text for Eikon: Further company coverage:

15 Feb 2018

BRIEF-Tecogen Inc To Sell Inverde E+ Cogeneration Units To 6 Apartment Buildings

* TECOGEN INC - ANNOUNCE WITHIN LAST 45 DAYS IT ENTERED INTO CONTRACTS TO SELL INVERDE E+ COGENERATION UNITS TO 6 APARTMENT BUILDINGS

23 Jan 2018

BRIEF-Tecogen's Co-Ceo To Retire As An Officer And Board Member

* TECOGEN'S CO-CEO TO RETIRE AS AN OFFICER AND BOARD MEMBER, WILL CONTINUE IN AN EMERITUS AND ADVISORY ROLE

29 Dec 2017

BRIEF-Tecogen Wins Order For Two Tecopower Units From New Jersey Pharmaceutical Company

* TECOGEN WINS ORDER FOR TWO TECOPOWER UNITS FROM NEW JERSEY PHARMACEUTICAL COMPANY

19 Dec 2017

BRIEF-Tecogen Q3 earnings per share $0.00

* Tecogen Inc - ‍backlog of products and installations was $14.5 million as of Q3 end, and stood at $16.8 million as of November 8, 2017​ Source text for Eikon: Further company coverage:

09 Nov 2017

BRIEF-Tecogen dissolves Ultratek joint venture

* Tecogen - ‍As part of disbursement, Tecogen will receive all its invested funds, $2 million in cash, and sole exclusive IP that it licensed to Ultratek​

26 Oct 2017

Earnings vs. Estimates